- Contractors
- Cidara Therapeutics Inc
Cidara Therapeutics Inc
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Cidara Therapeutics has 1 federal contract of $100,000 or more active since October 2023, with $58.1M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 1 since FY2024$58,051,983 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- Office of Assistant Secretary for Preparedness and Response$58.1M on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- FKP3JZ9RUNY9Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Development of CD388 As a Long-Lasting Prophylactic Anti-Viral Option for Protection Against the Health Impacts Caused by InfluenzaOffice of Assistant Secretary for Preparedness and Response · 75A50125C00017 | $58,051,983 | Sep 29, 2027in 10 months | CA |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response1 contract | $58,051,983 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $58,051,983 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| California1 contract | $58,051,983 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.
Get new notices like Cidara Therapeutics's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy